Warburg Pincus and Advent International, two private equity firms, are reportedly leading the way in the acquisition of Baxter International's biopharma solutions unit. Anonymous insiders have said that the potential deal could reach or exceed $4 billion. Other...
Warburg Pincus and Advent International in Advanced Talks to Acquire Baxter’s Biopharma Unit
read more